Goldman Sachs Group Inc Novartis Ag Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,059,361 shares of NVS stock, worth $316 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,059,361
Previous 3,535,902
13.48%
Holding current value
$316 Million
Previous $357 Million
17.11%
% of portfolio
0.05%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding NVS
# of Institutions
1,342Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.28 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.27 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$749 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$621 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$610 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $222B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...